Anna Hefner, PA in Coronado, CA - Clinical Nurse Specialist

Anna Hefner, PA is a Clinical Nurse Specialist based in Coronado, California. Anna Hefner is licensed to practice in California (license number 276061) and her current practice location is 230 Prospect Pl Ste 220, Coronado, California. She can be reached at her office (for appointments etc.) via phone at (619) 522-0399.

NPI number for Anna Hefner is 1588913537 and her current mailing address is 230 Prospect Pl Ste 220, Coronado, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1588913537.

Contact Information

	Anna Hefner, PA
	230 Prospect Pl Ste 220, Coronado, CA 92118-1978
	(619) 522-0399
	(619) 522-0375

Provider's Profile

Full Name	Anna Hefner
Gender	Female
Speciality	Clinical Nurse Specialist
Location	230 Prospect Pl Ste 220, Coronado, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1588913537
Provider Enumeration Date: 09/06/2012
Last Update Date: 09/06/2012

Medical Identifiers

Medical identifiers for Anna Hefner such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1588913537	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
364S00000X	Clinical Nurse Specialist	276061 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Anna Hefner is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Anna Hefner, PA 230 Prospect Pl Ste 220, Coronado, CA 92118-1978 Ph: (619) 522-0399	Anna Hefner, PA 230 Prospect Pl Ste 220, Coronado, CA 92118-1978 Ph: (619) 522-0399

News Archive

Lack of health insurance for many U.S. residents 'merely a symptom' of larger problem with costs, according to opinion piece

The major presidential candidates have "talked frequently" about proposals to expand health insurance to more U.S. residents but have failed to "recognize that lack of coverage is merely a symptom of a larger problem: the high cost of medical care," Dwight Bartlett, a former Social Security Administration chief actuary and a former Maryland insurance commissioner, writes in a Baltimore Sun opinion piece.

IRIN examines WHO process of translating research results into policy recommendations

IRIN examines the WHO's regulatory approval process for making evidence-based recommendations, noting, "Governments will generally not implement an intervention without the WHO stamp of approval."

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant, is providing an update regarding its efforts to file a Complete Response intended to gain U.S. Food and Drug Administration (FDA) marketing authorization of Surfaxin® for the prevention of respiratory distress syndrome (RDS) in premature infants.

Scientists discover powerful molecule that explains why people with anxiety use marijuana

/news/20200113/Research-could-help-explain-why-some-people-use-marijuana-when-stressed-or-anxious.aspx

Anna Hefner, PA - Clinical Nurse Specialist in Coronado, CA